TrialThe Journal of clinical investigation2020

Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation.

Susan Prockop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.